ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly repayments of long-term debt ($M) ($M)
Annual figures from Eli Lilly's filings and investor materials
Latest, FY2025
778
Period ended Dec 31, 2025
Change on a year earlier
+17.2%
664 in FY2024
History
19 years
Since FY2007
Sources
14
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Repayments of long-term debt ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 778 | +17.2% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 664 | – | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | -0 | -100.0% | Form 10-K (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 1,560 | -18.1% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 1,905 | +589.1% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 277 | -90.4% | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 2,866 | +184.1% | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 1,009 | +60.0% | Form 10-K (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 631 | +315,200.0% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 0.20 | -100.0% | Form 10-K (filed 2017-02-21) ↗ |
| FY2015 | Dec 31, 2015 | 1,956 | +89.0% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 1,035 | +9,755.2% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 10.5 | -99.3% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 1,511 | +2,349.1% | Form 10-K (filed 2014-02-19) ↗ |
| FY2011 | Dec 31, 2011 | 61.7 | +5,509.1% | Form 10-K (filed 2014-02-19) ↗ |
| FY2010 | Dec 31, 2010 | 1.10 | – | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | -0 | -100.0% | Form 10-K (filed 2010-02-22) ↗ |
| FY2008 | Dec 31, 2008 | 650 | -38.7% | Form 10-K (filed 2010-02-22) ↗ |
| FY2007 | Dec 31, 2007 | 1,060 | – | Form 10-K (filed 2010-02-22) ↗ |
Cite this data
StockData. (2026). Eli Lilly Repayments of long-term debt ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_debt_rep
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.